DNAmind PGx Report FAQ
he DNAmind PGx Report analyzes how your genetics may influence your response to mental health and neuropsychiatric medications. It is designed to be an exploratory, educational tool — not a clinical-grade report.
Looking for our clinically oriented and science team-validated PGx report? See the Medication Check (Pgx) Report, which is built for medical decision-making with your healthcare provider. To understand how the two reports differ, see our comparison article.
What Does the DNAmind PGx Report Cover?
DNAmind is focused on mental health medications, including:
- Antidepressants (SSRIs, SNRIs, TCAs, MAOIs)
- Antipsychotics
- ADHD medications
- Anxiolytics and sleep medications
- Mood stabilizers
It also examines additional genes related to neurotransmitters, receptors, and side-effect susceptibility — giving a broader picture than a conventional PGx report, but with more uncertainty.
👉 View a sample DNAmind PGx Report here.
How Is It Different from the Medication Check Report?
DNAmind intentionally casts a wider net. Alongside well-established gene–drug associations, it includes low-evidence and preliminary findings that may be hypothesis-driven or based on limited research. This makes it useful for exploration and conversation, but not for clinical decision-making on its own.
The Medication Check (PGx) Report, by contrast, includes only high- and moderate-evidence associations and is validated by our science and R&D teams. For a detailed comparison, see our comparison article.
How to Interpret Your Results
DNAmind categorizes medications similarly to the Medication Check report, using metabolizer types and precaution levels. For an explanation of how metabolizer types work (normal, intermediate, poor, rapid, ultra-rapid), see this article.
Important: This report does not replace your doctor’s advice. Always consult your healthcare provider before making any medication changes.
Intended Use
DNAmind is appropriate for:
- Educational exploration of how your genetics may relate to psychiatric medications
- Starting informed conversations with your healthcare provider
- Understanding possible genetic influences alongside other factors
DNAmind is not appropriate for starting, stopping, or adjusting medications without guidance from a healthcare professional.
Limitations
- Not clinically validated. This report has not been reviewed or validated by our science and R&D teams to the same standard as the Medication Check (Pgx) Report.
- Many included associations are preliminary, based on limited studies, or extrapolated from broader research.
- Like all PGx reports, it focuses on genetic factors only. Age, weight, medical conditions, lifestyle, and other medications also affect drug response.
- It does not replace your doctor's advice, diagnose conditions, or serve as a standalone basis for medication changes.
Important Safety Notice
Always consult a qualified healthcare professional before making any changes to your medications. Treat DNAmind results as a starting point for discussion — not a prescription.